Q3 2024 Earnings Call Transcript November 12, 2024 Operator: Thank you for standing by and welcome to Heron Therapeutics ...

Yardstik is on a mission to reduce people-related risk. And it's catching on. Experiencing massive growth since launch, the company has seen revenue and total screens run increase by 100% ...

Earlier, I spoke about VAN. And the Nopain Act, both of which will have an impact in 2025. Right now. We are seeing early results that the Crosslink partnership is beginning to drive growth. Our team ...

Reported positive YTD 2024 Adjusted EBITDA of $1.4 million Company expects Q4 2024 Net Revenue in the range of $37 million - $43 million ZYNRELEF® (bupivacaine ...

Count defense tech bulls among the investor groups buoyed by last week’s election of Donald Trump as president. Some ...

In terms of consumption, the North American region gains maximum traction over the projected years. Owing to demand from ...

根据最近的SEC文件显示，Weave Communications, Inc. (NYSE:WEAV)的主要股东Crosslink Capital Inc.已出售该公司125,000股股票。这些股票以平均价格13.99美元出售，交易总额约为175万美元。此次出售发生在2024年11月6日，交易完成后Crosslink持有的Weave Communications股份约为790万股。

Pacira BioSciences(PCRX)发布Q3财报，2024财年前三财季累计收入5.14亿美元，去年同期累计收入为4.94亿美元，同比增长4.05%。 2024财年前三财季累计净亏损1.16亿美元，去年同期累计净利润为1708.50万美元。 本财年累计基本每股收益为-2.5美元，去年同期为0.37美元。 公司所属行业为制药。 营业收入-1.39亿 2910.50万 1379.90万 33 ...